Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin.
CONCLUSION: Pantoprazole did not ameliorate cisplatin ototoxicity or nephrotoxicity. The decrease in GFRcysC and increase in N-acetyl-ß-glucosaminidase (NAG) and creatinine demonstrate that these biomarkers can quantify cisplatin glomerular and proximal tubular toxicity. OCT2 inhibition by pantoprazole did not appear to alter antitumor response or survival.
PMID: 29445029 [PubMed - as supplied by publisher]
Source: The Oncologist - Category: Cancer & Oncology Authors: Fox E, Levin K, Zhu Y, Segers B, Balamuth N, Womer R, Bagatell R, Balis F Tags: Oncologist Source Type: research
More News: Audiology | Bone Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Children | Lessons | Methotrexate | Organic | Osteosarcoma | Pantoprazole | Protonix | Tinnitus | Toxicology | Urology & Nephrology